Research desk · PRNAF · Nasdaq
PRNAF Stock
SEC financials, peer compare, and chart. Scores open the matching desk. Research only — not advice.
ALTERITY THERAPEUTICS LTD · Pharmaceutical Preparations
ALTERITY THERAPEUTICS LTD financial statements, chart, and peer compare from SEC filings.
ALTERITY THERAPEUTICS LTD (PRNAF) discovers, develops, or markets pharmaceutical products.
- Market cap
- —
- P/E
- —
- Op. margin
- —
- Profit margin
- —
- FCF margin
- —
- ROE
- 60.52%
Related Health Care stocks: CYDY stock financials · ALZN stock financials · PMCB stock financials · GLUE stock financials · CAPR stock financials
PRNAF financial statements
Each Compare name is its own block of years. Filing lines are SEC reports; P/E and price sit on that name’s TTM column only.
PRNAF stock peer compare
Each bar is that name’s percent vs its last TTM, on one zero line. Zero is unchanged. This ticker is the black bar.
Focus chart
Zero is unchanged vs last TTM. Every name is a percent for the metric you pick.
PRNAF stock peer headlines
Yahoo Finance RSS for PRNAF and the names in Compare.
| Ticker | Date | Headline |
|---|---|---|
| Loading headlines… | ||
PRNAF stock price chart
Overlays follow the Compare table.
PRNAF stock — research snapshot
Screen strengths and watchouts for PRNAF stock from the latest Misprise snapshot.
Strengths
- ROA 50.5% — strong returns on assets.
- ROE 60.5% — efficient equity returns.
- Current ratio 6.17 — liquidity cushion.
Watchouts
- EPS CAGR negative — earnings trajectory is soft.
- Rev CAGR 5Y —
- Rev CAGR 3Y —
- EPS CAGR 5Y —
- EPS CAGR 3Y -27.6%
- FCF CAGR 5Y 26.0%
- FCF CAGR 3Y 28.5%
PRNAF stock FAQs
Short answers for PRNAF stock — statements, sector, and how this page is meant to be used.
What is PRNAF stock?
ALTERITY THERAPEUTICS LTD (PRNAF) discovers, develops, or markets pharmaceutical products. PRNAF stock sits in Health Care (Pharmaceutical Preparations), listed on Nasdaq.
Where can I find ALTERITY THERAPEUTICS LTD financial statements?
ALTERITY THERAPEUTICS LTD financial statements — income statement, balance sheet, and cash flow — are on this PRNAF stock page, parsed from SEC 10-K and 10-Q filings. Use Annual or Quarterly, then the statement tabs. Research only.
What happened to PRNAF stock?
This page is a research snapshot of ALTERITY THERAPEUTICS LTD (PRNAF) from the latest SEC filings in the Misprise database as of FY2023. It is not a news feed or a delisting notice. Open the financial statements, chart, and peer compare below, then read the filings. Research only — not financial advice.
Does this page show the PRNAF stock price?
The live chart on this PRNAF stock page is the same TradingView chart as the screener. Statement tables use SEC filings. Any price or multiple on the TTM column is a market snapshot from the last seed, not a real-time quote. Research only.
What sector is PRNAF stock in?
ALTERITY THERAPEUTICS LTD is classified in Pharmaceutical Preparations, inside the Health Care sector, and trades on Nasdaq. This page is a research snapshot, not a full company profile.
How do I read PRNAF financial statements?
Start with this ticker’s block (TTM, then its fiscal years or quarters). Each Compare name is a separate block of its own periods — not mixed by year. A blank is a period we do not have, not a zero. Research only — not a buy or sell.
Where does the PRNAF statement data come from?
Income, balance sheet, and cash-flow lines are parsed from SEC company filings (10-K / 10-Q and 20-F). TTM is the last four reported quarters added together, not a separate filing. P/E, forward P/E, price, and market cap are a market quote at last seed — trailing P/E from the quote when available, otherwise last price divided by TTM EPS. They are not 10-K line items and appear on the TTM column only. Research only — not financial advice.
Where can I find the PRNAF income statement, balance sheet, and cash flow?
On this PRNAF stock page, open Financial statements and use the Income, Balance sheet, and Cash flow tabs. Growth and valuation sit under More. Filing figures are from SEC reports; valuation multiples are the market snapshot described above.
What is the Misprise Score for PRNAF stock?
PRNAF stock currently scores 31/100 (Watch / incomplete (<60)). ALTERITY THERAPEUTICS LTD scores weaker or incomplete on durable growth/quality inputs — leverage, coverage, and recent results deserve extra scrutiny. The score is a screen of quality, growth, and balance-sheet inputs — not a price target. Compare it in the Misprise screener; it is not a separate score page.
How is the PRNAF comparison winner decided?
Lead and Tie follow the number printed on each factor row, not a blended category score. Growth, quality, score, current ratio, and coverage: the higher figure leads. Value multiples (P/E, PEG, P/B, P/S) and debt ratios: the lower figure leads. Tie appears only when those printed numbers match. The header winner is whoever takes more of those five rows. CAGR uses the 5-year horizon and drops to 3-year only when both names report it. Research only — not a buy or sell.
What is the Anomaly Score on this PRNAF page?
Anomaly Score is how unusual a filing pattern is versus this company’s own history and its industry — not the same as Misprise Score. A high anomaly with a weak Misprise Score is often a noisy name. Open the anomaly detector to see the flag. Research only — not financial advice.
What does the green grant dot mean on PRNAF stock?
A green circle next to the title means this ticker appears in the Misprise grants calendar with a recent federal award (USASpending / SAM). Tap the dot for date, agency, and amount when available. It is a research flag only — not a buy or sell signal.
Is PRNAF stock a buy?
No recommendation either way. This PRNAF stock page organizes statements, ratios, and peers so you can do your own work. It is educational only — not advice to buy or sell ALTERITY THERAPEUTICS LTD.